Left Ventricular Diastolic Dysfunction as Predictor of Unfavorable Prognosis After ESUS

References

• Donkor ES. Stroke in the 21st century: a snapshot of the burden, epidemiology, and quality of life. Stroke Res Treat. 2018;3238165. doi:10.1155/2018/3238165
   PubMed Web of Science ®Google Scholar
• Grysiewicz RA, Thomas K, Pandey DK. Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors. Neurol Clin. 2008;26(4):871–vii. doi:10.1016/j.ncl.2008.07.003
   PubMed Web of Science ®Google Scholar
• Chung JW, Park SH, Kim N, et al. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification and vascular territory of ischemic stroke lesions diagnosed by diffusion-weighted imaging. J Am Heart Assoc. 2014;3(4):e001119. doi:10.1161/JAHA.114.001119
   Web of Science ®Google Scholar
• Gąsiorek PE, Banach M, Maciejewski M, et al. Stroke as a result of cardioembolism — characteristic features in the context of diagnostic methods and secondary prevention. Folia Cardiol. 2018.
   Google Scholar
• Gąsiorek PE, Banach M, Maciejewski M, et al. Established and potential echocardiographic markers of embolism and their therapeutic implications in patients with ischemic stroke. Cardiol J. 2019;26(5):438–450. PMID: 29718528. doi:10.5603/CJ.a2018.0046.
   Web of Science ®Google Scholar
• Ntaios G. Embolic stroke of undetermined source: JACC review topic of the week. J Am Coll Cardiol. 2020;75(3):333–340. doi:10.1016/j.jacc.2019.11.024
   PubMed Web of Science ®Google Scholar
• Hart RG, Diener HC, Coutts SB, et al.; Cryptogenic Stroke/ESUS International Working Group. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13(4):429–438. doi:10.1016/S1474-4422(13)70310-7.
   PubMed Web of Science ®Google Scholar
• Geisler T, Mengel A, Ziemann U, Poli S. Management of embolic stroke of undetermined source (ESUS). Drugs. 2018;78(8):823–831. doi:10.1007/s40265-018-0912-8
   Web of Science ®Google Scholar
• Gąsiorek P, Banach M, Sakowicz A, et al. The potential role of inflammation in cryptogenic stroke. Adv Med Sci. 2019;64(2):381–387. doi:10.1016/j.advms.2019.06.001
   Web of Science ®Google Scholar
• Gąsiorek P, Sakowicz A, Banach M, von Haehling S, Bielecka-Dabrowa A. Arterial stiffness and indices of left ventricular diastolic dysfunction in patients with embolic stroke of undetermined etiology. Dis Markers. 2019;2019:9636197. PMID: 31612072; PMCID: PMC6757252. doi:10.1155/2019/9636197.
   Web of Science ®Google Scholar
• Bielecka-Dabrowa A, Gasiorek P, Sakowicz A, Banach M. The cardiovascular predictors of clinical outcomes in patients after ischemic stroke of undetermined etiology. Eur Heart J. 2019;40(Supplement):1511. doi:10.1093/eurheartj/ehz748.0877
   Google Scholar
• Saric M, Armour AC, Arnaout MS, et al. Guidelines for the use of echocardiography in the evaluation of a cardiac source of embolism. J Am Soc Echocardiography. 2016;29(1):1–42.
   PubMed Web of Science ®Google Scholar
• Holland DJ, Sacre JW, Leano RL, Marwick TH, Sharman JE. Contribution of abnormal central blood pressure to left ventricular filling pressure during exercise in patients with heart failure and preserved ejection fraction. J Hypertens. 2011;29(7):1422–1430. doi:10.1097/HJH.0b013e3283480ddc
   Web of Science ®Google Scholar
• Hart RG, Catanese L, Perera KS, Ntaios G, Connolly SJ. Embolic stroke of undetermined source: a systematic review and clinical update. Stroke. 2017;48(4):867–872. doi:10.1161/STROKEAHA.116.016414
   PubMed Web of Science ®Google Scholar
• Hart RG, Sharma M, Mundl H, et al. Rivaroxaban for stroke prevention after embolic stroke of undetermined source. N Engl J Med. 2018;378:2191–2201. doi:10.1056/NEJMoa1802686
   PubMed Web of Science ®Google Scholar
• Diener HC, Sacco RL, Easton JD, et al. Dabigatran for prevention of stroke after embolic stroke of undetermined source. N Engl J Med. 2019;380:1906–1917. doi:10.1056/NEJMoa1813959
   PubMed Web of Science ®Google Scholar
• Authors/Task Force Members, ESC Committee for Practice Guidelines (CPG), & ESC National Cardiac Societies. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140–205. doi:10.1016/j.atherosclerosis.2019.08.014
   PubMed Web of Science ®Google Scholar
• Bardagjy AS, Steinberg FM. Relationship between HDL functional characteristics and cardiovascular health and potential impact of dietary patterns: a narrative review. Nutrients. 2019;11(6):1231. doi:10.3390/nu11061231
   Web of Science ®Google Scholar
• Ilhan N, Susam S, Canpolat O, Belhan O. The emerging role of leptin, adiponectin and visfatin in ischemic/hemorrhagic stroke. Br J Neurosurg. 2019;33(5):504–507. doi:10.1080/02688697.2019.1578862
   PubMed Web of Science ®Google Scholar
• Sasaki M, Otani T, Kawakami M, Ishikawa SE. Elevation of plasma retinol-binding protein 4 and reduction of plasma adiponectin in subjects with cerebral infarction. Metabolism. 2010;59(4):527–532. doi:10.1016/j.metabol.2009.08.015
   Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. [Eur Heart J. 2019 Feb 1;40(5):475]. Eur Heart J. 2018;39(33):3021–3104. doi:10.1093/eurheartj/ehy339
   PubMed Web of Science ®Google Scholar
• Tykarski A, Filipiak JK, Januszewicz A, et al. Zasady postępowania w nadciśnieniu tętniczym — 2019 rok. Nadcisnienie Tetnicze w Praktyce. 2019;5(1):1–86.
   Google Scholar
• Chen Z, Mo J, Xu J, et al. Effect of low diastolic blood pressure to cardiovascular risk in patients with ischemic stroke or transient ischemic attacks under different systolic blood pressure levels. Front Neurol. 2020;11:356. doi:10.3389/fneur.2020.00356
   Web of Science ®Google Scholar
• Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: a Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50:e344–e418. doi:10.1161/STR.0000000000000211
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: the Task Force for the management of atrial fi brillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO). Eur Heart J. 2016;37:2893–2962. doi:10.1093/eurheartj/ehw210
   PubMed Web of Science ®Google Scholar
• Wachter R, Gröschel K, Gelbrich G, et al. Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial. Lancet Neurol. 2017;16(4):282–290. doi:10.1016/S1474-4422(17)30002-9
   Web of Science ®Google Scholar
• Campal JM, Torres MA, Borque PS, et al. Detecting atrial fibrillation in patients with an embolic stroke of undetermined source (from the DAF-ESUS registry). Am J Cardiol. 2020;125(3):409–414. doi:10.1016/j.amjcard.2019.10.050
   Web of Science ®Google Scholar
• Kosiuk J, Van Belle Y, Bode K, et al. Left ventricular diastolic dysfunction in atrial fibrillation: predictors and relation with symptom severity. J Cardiovasc Electrophysiol. 2012;23:1073–1077. doi:10.1111/j.1540-8167.2012.02368.x
   Web of Science ®Google Scholar
• Rosenberg MA, Manning WJ. Diastolic dysfunction and risk of atrial fibrillation: a mechanistic appraisal. Circulation. 2012;126:2353–2362. doi:10.1161/CIRCULATIONAHA.112.113233
   PubMed Web of Science ®Google Scholar
• Seo JY, Lee KB, Lee JG, et al. Implication of left ventricular diastolic dysfunction in cryptogenic ischemic stroke. Stroke. 2014;45:2757–2761. doi:10.1161/STROKEAHA.114.006108
   Web of Science ®Google Scholar
• Ryu W-S, Park J-B, Ko S-B, et al. Diastolic dysfunction and outcome in acute ischemic stroke. Cerebrovasc Dis. 2016;41:148–155. doi:10.1159/000442006
   PubMed Web of Science ®Google Scholar
• Arai R, Suzuki S, Semba H, et al. The predictive role of E/e’ on ischemic stroke and atrial fibrillation in Japanese patients without atrial fibrillation. J Cardiol. 2018;72(1):33–41. doi:10.1016/j.jjcc.2018.01.001
   Web of Science ®Google Scholar